Label Changes for:

Reyataz (Atazanavir Sulfate) Capsules

August 2013

Changes have been made to the ADVERSE REACTIONS sections of the safety label.

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – August 2013

 

ADVERSE REACTIONS

Postmarketing Experience
Skin and Appendages:
Hide
(web5)